The technique of targeted sequence capture and massively parallel sequencing makes it very easy and cost-effective to screen large numbers of genes, and might cover noncoding sequences of some of them, such as GJB2. This approach could prove to be very useful for genetic diagnosis in cases of NSHL [31], with predictable benefits for genetic counselling of the affected families. The gene discussed is GJB2; the disease is nodular sclerosis classical Hodgkin lymphoma.